Today's top medical abstracts
Oncology
Become a Member Today!
Email
Password
Remember me
Forgot your Password?

Invite Code?

Home
General Oncology
For Practicing
Oncologists
Conferences
Jobs
Newsletters
My Library
Topics in
Oncology
        Alternative Therapies
        Anemia/Polycythemia
        BMT/SCT
        Basic Science/Genetics
        Bone/Cartilage
        Breast
        Carcinogenesis
        Coagulation/Bleeding Dz
        Colorectal Cancer/Polyps
        Dermatologic Oncology
        Diagnostics/Radiology
        Economics of Medicine
        Endocrine Oncology
        GI Oncology
        Gynecologic Oncology
        Head and Neck
        Hepatobiliary/Pancreas
        Leukemia/Lymphoma
        Lung/Thoracic Oncology
        Myeloproliferative Dz
        Neurologic Oncology
        Pain/Palliative Care
        Pediatric Heme/Oncology
        Pharmacology/Therapy
        Popular Press
        Renal/Urologic
        Side Effects
        Soft Tissue/Sarcoma
        Transfusion Medicine
 
Help
Resource Center
RSS News Feeds
Send Newsletter
to a Friend
 
Sponsor
For Practicing Oncologists
Providers Satisfied with Carriers/MACs
Roberta Buell, MBA, Sausalito Healthcare Partners
Cancer Science: Mutations in the ALK Receptor Kinase cause Neuroblastoma
Sara Hartley, MDLinx Oncology
Technology Advances: Laser Microscopy Offers Vista of Real-Time Cell Movements
Dorothy J. Schirf, MD, MDLinx Oncology
  See all
prostate cancer risk;Folate and Vitamin B12 Article Summary

Click the title below to leave the MDLinx Network and go to the Journal's Website
Circulating concentrations of folate and vitamin B12 in relation to prostate cancer risk: results from the European Prospective Investigation into Cancer and Nutrition study
Cancer Epidemiology, Biomarkers & Prevention, 02/14/08
Print     Email This Article     Save in My Library   Free Abstract
Johansson M et al. - In a trial to investigate the relationship between prostate cancer risk and circulating concentrations of folate and vitamin B12, it seems that results do not provide strong support for an association between prostate cancer risk and circulating concentrations of folate or vitamin B12

Methods
  • Circulating concentrations of folate and vitamin B12 were analyzed in 869 cases and 1174 controls, individually matched on center, age, and date of recruitment
  • Relative risks (RR) for prostate cancer were estimated using conditional logistic regression models

Results
  • No significant associations were observed for circulating concentrations of folate or vitamin B12 with prostate cancer risk
  • RRs for a doubling in folate and vitamin B12 concentrations were 1.03 and 1.12, respectively
  • In the subgroup of cases diagnosed with advanced stage prostate cancer, elevated concentrations of vitamin B12 were associated with increased risk
  • No other subgroup analyses resulted in a statistically significant association

Sponsor
Read a Different Specialty
Allergy/Immunology
Anesthesiology
Cardiology
Dermatology
Drugs
Emergency Medicine
Endocrinology
ENT
Family Medicine
Gastroenterology
Hematology-Oncology
Infectious Disease
Internal Medicine
Nephrology
Neurology
OB/Gyn
Ophthalmology
Orthopedics
Pediatrics
Psychiatry
Pulmonology
Radiology
Rheumatology
Surgery
Urology
Profession Index
Dentist
Hospital Administrator
Nurse
    Medical Students
Nurse Practitioner
Pharma/Drug Marketer
    Pharmacist
Physician
Physician Assistants
Article Search
Keyword:
Search:
Published within:
Sort By:
Date Relevance
    
Sponsor
Sponsor
About MDLinx  |  Contact  |  Advertise with MDLinx  |  Site Map  |  Privacy Policy  |  Terms of Use  |  Sign Up For Newsletters  |  Recommend this Site

English |  Español |  Français |  Deutsch |  中文 |  Руccкий |  Norsk |  Nederlands |  Português |  Italiano

©1999-2008 MDLinx, Inc.